Chestnut Hill, MA, United States of America

Xinyuan Edward Wu

This inventor holds 22 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Hydra Biosciences, Inc., Boehringer Ingelheim International Gmbh, Eli Lilly and Company. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinyuan Edward Wu. Retrieved from https://idiyas.com/inventor/xinyuan-edward-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 8)

% Patents Active = 86.4

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 38(Granted Patents)

Location History:

Newton, MA (US) (2010 - 2023)
Chestnut Hill, MA (US) (2020 - 2024)

Company Filing History:

8 out of 49

Hydra Biosciences, Inc.

patents

4 out of 1,561

Boehringer Ingelheim International Gmbh

patents

3 out of 4,509

Eli Lilly and Company

patents

4. 2 out of 2

Astellas Engineered Small Molecules US, Incorporated

Alantos Pharmaceuticals Holding, Inc.

Atlantos Pharmaceuticals Holding, Inc.

patent

9. 1 out of 59

Cubist Pharmaceuticals, Incorporated

Tango Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514858 - CD38 inhibitors (2026-01-06),

2. 12435061 - Compounds and compositions for use in treating skin disorders (2025-10-07),

3. 12071433 - HMOX1 inducers (2024-08-27),

4. 12043607 - HDAC inhibitors and therapeutic use thereof (2024-07-23),

5. 11807621 - Compounds and compositions for use in treating skin disorders (2023-11-07),

6. RE49699 - Inhibitors of TRPC6 (2023-10-17),

7. 11485740 - Inhibitors of TRPC6 (2022-11-01),

8. 11161849 - Inhibiting the transient receptor potential al ion channel (2021-11-02),

9. 10889568 - Inhibitors of TRPC6 (2021-01-12),

10. 10800757 - Inhibitors of TRPC6 (2020-10-13),

11. 10766888 - HMOX1 inducers (2020-09-08),

12. 10519158 - Inhibiting the transient receptor potential A1 ion channel (2019-12-31),

13. 10428072 - Inhibiting the transient receptor potential A1 ion channel (2019-10-01),

14. 10221177 - Inhibiting the transient receptor potential A1 ion channel (2019-03-05),

15. 9505756 - Compounds useful for treating disorders related to TRPA1 (2016-11-29),

Title: The Innovative Journey of Xinyuan Edward Wu

Introduction: Xinyuan Edward Wu, a pioneering inventor hailing from Chestnut Hill, MA, is a trailblazing woman in the world of technology and innovation.

Latest Patents: Xinyuan Edward Wu's latest patents include groundbreaking advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for remote patient monitoring.

Career Highlights: With a career spanning over two decades, Xinyuan Edward Wu has made significant contributions to various fields such as robotics, renewable energy, and biotechnology. Her innovative solutions have revolutionized industries and improved the quality of life for many.

Collaborations: Xinyuan Edward Wu has collaborated with leading research institutions, top universities, and renowned companies to bring her inventions to life. Her collaborative spirit and dedication to excellence have led to numerous successful projects and patents.

Conclusion: Xinyuan Edward Wu's passion for innovation, coupled with her relentless drive to push the boundaries of technology, has solidified her position as a prominent figure in the world of inventors. Her remarkable achievements continue to inspire future generations to pursue their innovative ideas and change the world for the better.

Profile summary based on public USPTO records.